Please enable JavaScript to continue using this application.

Compare $ACRV vs $EQ | Chartloom

Compare

$ACRV vs $EQ

Acrivon Therapeutics Inc · Equillium Inc

ACRV

Acrivon Therapeutics Inc

Equillium Inc

Compare $ACRV vs $EQ

Comparing Acrivon Therapeutics Inc and Equillium Inc

ACRVAcrivon Therapeutics Inc

EQEquillium Inc

ACRVAcrivon Therapeutics Inc

Market cap

$82M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-22.4%

52W performance

1.6%

FCF yield

-78.5%

EQEquillium Inc

Market cap

$89M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-7.8%

52W performance

-4.1%

FCF yield

-22.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACRV

Detailed metrics comparison

ACRV

Acrivon Therapeutics Inc

Equillium Inc

Market Cap

ACRV$82M

EQ$89M

Enterprise Value

ACRV$40M

EQ$32M

Price

ACRV$1.91

EQ$1.41

P/E Ratio

ACRVN/A

EQN/A

P/S Ratio

ACRV0.00x

EQ2.18x

EV/Sales

ACRV0.00x

EQ0.78x

EV/EBITDA

ACRV0.00x

EQ0.00x

P/B Ratio

ACRV0.98x

EQ1.60x

P/FCF Ratio

ACRVN/A

EQN/A

EV/FCF

ACRV-0.63x

EQ-1.59x

PEG Ratio

ACRVN/A

EQN/A

Forward P/E (NTM)

ACRVN/A

EQN/A

Forward P/S (NTM)

ACRVN/A

EQN/A

Revenue (TTM)

ACRV$0

EQ$0

Revenue Growth (YoY)

ACRVN/A

EQN/A

Forward Rev Growth

ACRV406.9%

EQ0.0%

Gross Margin (TTM)

ACRV0.0%

EQ0.0%

Operating Margin (TTM)

ACRV0.0%

EQ0.0%

EBITDA Margin (TTM)

ACRV0.0%

EQ0.0%

Net Margin (TTM)

ACRV0.0%

EQ0.0%

FCF Margin (TTM)

ACRVN/A

EQN/A

Net Income (TTM)

ACRV$-74M

EQ$-18M

FCF (TTM)

ACRV$-64M

EQ$-20M

EPS (TTM)

ACRV-$1.77

EQ-$0.15

ROE (TTM)

ACRV-7014.0%

EQ-6143.0%

ROA (TTM)

ACRV-6161.0%

EQ-5372.0%

ROIC (TTM)

ACRV-7014.0%

EQ-6143.0%

Cash

ACRV$41M

EQ$57M

Debt

ACRV$0

EQ$0

Net Cash/Debt

ACRV$41M

EQ$57M

Current Ratio (TTM)

ACRV7.99x

EQ23.40x

Quick Ratio (TTM)

ACRV7.86x

EQ23.07x

Debt/Equity (TTM)

ACRV0.00x

EQ0.00x

Debt/Assets (TTM)

ACRV0.0%

EQ0.0%

Interest Coverage (TTM)

ACRVN/A

EQN/A

Net Debt/EBITDA (TTM)

ACRV0.00x

EQ0.00x

Beta

ACRV1.95

EQ2.07

52W Performance

ACRV1.6%

EQ-4.1%

YTD Performance

ACRV-22.4%

EQ-7.8%

% from 52W High

ACRV-46.3%

EQ-60.2%

% from 52W Low

ACRV50.4%

EQ85.5%

Asset Turnover (TTM)

ACRV0.00x

EQ1.12x

FCF Yield (TTM)

ACRV-78.5%

EQ-22.5%

Earnings Yield (TTM)

ACRV-90.8%

EQ-20.2%

Dividend Yield (TTM)

ACRVN/A

EQN/A

Rule of 40

ACRV0.0

EQ0.0

EV/GP/RG

ACRVN/A

EQN/A

Ticker research

View ACRV research View EQ research

Metric	ACRV Acrivon Therapeutics Inc	EQ Equillium Inc
Market & Valuation
Market Cap	$82M	$89M
Enterprise Value	$40M	$32M
Price	$1.91	$1.41
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	2.18x
EV/Sales	0.00x	0.78x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.98x	1.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.63x	-1.59x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	406.9%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-74M	$-18M
FCF (TTM)	$-64M	$-20M
EPS (TTM)	-$1.77	-$0.15
ROE (TTM)	-7014.0%	-6143.0%
ROA (TTM)	-6161.0%	-5372.0%
ROIC (TTM)	-7014.0%	-6143.0%
Financial Health
Cash	$41M	$57M
Debt	$0	$0
Net Cash/Debt	$41M	$57M
Current Ratio (TTM)	7.99x	23.40x
Quick Ratio (TTM)	7.86x	23.07x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.95	2.07
52W Performance	1.6%	-4.1%
YTD Performance	-22.4%	-7.8%
% from 52W High	-46.3%	-60.2%
% from 52W Low	50.4%	85.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.12x
FCF Yield (TTM)	-78.5%	-22.5%
Earnings Yield (TTM)	-90.8%	-20.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACRV research	View EQ research

Valuation

P/S Ratio

ACRV

0.00x

2.18x

EV/FCF

-1.59x

ACRV

-0.63x

Growth & revenue

Forward Revenue Growth

ACRV

406.9%

0.0%

Profitability & performance

Gross Margin

ACRV

0.0%

ROE

-6143.0%

ACRV

-7014.0%

FCF Yield %

-22.5%

ACRV

-78.5%

52-Week Performance

ACRV

1.6%

-4.1%

Detailed metrics comparison

ACRV

Acrivon Therapeutics Inc

Equillium Inc

Market Cap

ACRV$82M

EQ$89M

Enterprise Value

ACRV$40M

EQ$32M

Price

ACRV$1.91

EQ$1.41

P/E Ratio

ACRVN/A

EQN/A

P/S Ratio

ACRV0.00x

EQ2.18x

EV/Sales

ACRV0.00x

EQ0.78x

EV/EBITDA

ACRV0.00x

EQ0.00x

P/B Ratio

ACRV0.98x

EQ1.60x

P/FCF Ratio

ACRVN/A

EQN/A

EV/FCF

ACRV-0.63x

EQ-1.59x

PEG Ratio

ACRVN/A

EQN/A

Forward P/E (NTM)

ACRVN/A

EQN/A

Forward P/S (NTM)

ACRVN/A

EQN/A

Revenue (TTM)

ACRV$0

EQ$0

Revenue Growth (YoY)

ACRVN/A

EQN/A

Forward Rev Growth

ACRV406.9%

EQ0.0%

Gross Margin (TTM)

ACRV0.0%

EQ0.0%

Operating Margin (TTM)

ACRV0.0%

EQ0.0%

EBITDA Margin (TTM)

ACRV0.0%

EQ0.0%

Net Margin (TTM)

ACRV0.0%

EQ0.0%

FCF Margin (TTM)

ACRVN/A

EQN/A

Net Income (TTM)

ACRV$-74M

EQ$-18M

FCF (TTM)

ACRV$-64M

EQ$-20M

EPS (TTM)

ACRV-$1.77

EQ-$0.15

ROE (TTM)

ACRV-7014.0%

EQ-6143.0%

ROA (TTM)

ACRV-6161.0%

EQ-5372.0%

ROIC (TTM)

ACRV-7014.0%

EQ-6143.0%

Cash

ACRV$41M

EQ$57M

Debt

ACRV$0

EQ$0

Net Cash/Debt

ACRV$41M

EQ$57M

Current Ratio (TTM)

ACRV7.99x

EQ23.40x

Quick Ratio (TTM)

ACRV7.86x

EQ23.07x

Debt/Equity (TTM)

ACRV0.00x

EQ0.00x

Debt/Assets (TTM)

ACRV0.0%

EQ0.0%

Interest Coverage (TTM)

ACRVN/A

EQN/A

Net Debt/EBITDA (TTM)

ACRV0.00x

EQ0.00x

Beta

ACRV1.95

EQ2.07

52W Performance

ACRV1.6%

EQ-4.1%

YTD Performance

ACRV-22.4%

EQ-7.8%

% from 52W High

ACRV-46.3%

EQ-60.2%

% from 52W Low

ACRV50.4%

EQ85.5%

Asset Turnover (TTM)

ACRV0.00x

EQ1.12x

FCF Yield (TTM)

ACRV-78.5%

EQ-22.5%

Earnings Yield (TTM)

ACRV-90.8%

EQ-20.2%

Dividend Yield (TTM)

ACRVN/A

EQN/A

Rule of 40

ACRV0.0

EQ0.0

EV/GP/RG

ACRVN/A

EQN/A

Ticker research

View ACRV research View EQ research

Metric	ACRV Acrivon Therapeutics Inc	EQ Equillium Inc
Market & Valuation
Market Cap	$82M	$89M
Enterprise Value	$40M	$32M
Price	$1.91	$1.41
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	2.18x
EV/Sales	0.00x	0.78x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.98x	1.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.63x	-1.59x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	406.9%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-74M	$-18M
FCF (TTM)	$-64M	$-20M
EPS (TTM)	-$1.77	-$0.15
ROE (TTM)	-7014.0%	-6143.0%
ROA (TTM)	-6161.0%	-5372.0%
ROIC (TTM)	-7014.0%	-6143.0%
Financial Health
Cash	$41M	$57M
Debt	$0	$0
Net Cash/Debt	$41M	$57M
Current Ratio (TTM)	7.99x	23.40x
Quick Ratio (TTM)	7.86x	23.07x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.95	2.07
52W Performance	1.6%	-4.1%
YTD Performance	-22.4%	-7.8%
% from 52W High	-46.3%	-60.2%
% from 52W Low	50.4%	85.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.12x
FCF Yield (TTM)	-78.5%	-22.5%
Earnings Yield (TTM)	-90.8%	-20.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACRV research	View EQ research